Your browser doesn't support javascript.
loading
Spironolactone and perioperative atrial fibrillation occurrence in cardiac surgery patients: Rationale and design of the ALDOCURE trial.
Alexandre, Joachim; Ollitrault, Pierre; Fischer, Marc-Olivier; Fellahi, Jean-Luc; Rozec, Bertrand; Cholley, Bernard; Dolladille, Charles; Chequel, Mathieu; Allouche, Stéphane; Legallois, Damien; Saplacan, Vladimir; Buklas, Dimitrios; Beygui, Farzin; Parienti, Jean-Jacques; Milliez, Paul.
Afiliação
  • Alexandre J; Department of Pharmacology, CHU de Caen, Caen, F-14000, France; Université Caen Normandie, Medical School, UNICAEN, CHU Caen, EA, 4650, Signalisation, électrophysiologie et imagerie des lésions d'ischémie-reperfusion myocardique, Caen F-14000, France. Electronic address: alexandre-j@chu-caen.fr.
  • Ollitrault P; Department of Cardiology, CHU de Caen, Caen, F-14000, France.
  • Fischer MO; Université Caen Normandie, Medical School, UNICAEN, CHU Caen, EA, 4650, Signalisation, électrophysiologie et imagerie des lésions d'ischémie-reperfusion myocardique, Caen F-14000, France; Pôle Réanimations Anesthésie SAMU/SMUR, CHU de Caen, Caen, F-14000, France.
  • Fellahi JL; Service d'Anesthésie-Réanimation, Hôpital Cardiologique Louis Pradel, Hospices Civils de Lyon, 59 Boulevard Pinel, Lyon Cedex 03, France.
  • Rozec B; Service d'Anesthésie-Réanimation, Hôpital Laënnec, Centre, Hospitalier Universitaire, Nantes, France.
  • Cholley B; Anesthesiology and Critical Care Medicine Department, Hôpital Européen Georges Pompidou, AP-, HP, and Université Paris Descartes-Sorbonne Paris Cité, Paris, France.
  • Dolladille C; Department of Pharmacology, CHU de Caen, Caen, F-14000, France; Department of Cardiology, CHU de Caen, Caen, F-14000, France.
  • Chequel M; Department of Cardiology, CHU de Caen, Caen, F-14000, France.
  • Allouche S; Université Caen Normandie, Medical School, UNICAEN, CHU Caen, EA, 4650, Signalisation, électrophysiologie et imagerie des lésions d'ischémie-reperfusion myocardique, Caen F-14000, France; Department of Biochemistry, CHU de Caen, Caen, F-14000, France.
  • Legallois D; Université Caen Normandie, Medical School, UNICAEN, CHU Caen, EA, 4650, Signalisation, électrophysiologie et imagerie des lésions d'ischémie-reperfusion myocardique, Caen F-14000, France; Department of Cardiology, CHU de Caen, Caen, F-14000, France.
  • Saplacan V; Department of Cardiac Surgery, CHU de Caen, Caen, F-14000, France.
  • Buklas D; Department of Cardiac Surgery, CHU de Caen, Caen, F-14000, France.
  • Beygui F; Université Caen Normandie, Medical School, UNICAEN, CHU Caen, EA, 4650, Signalisation, électrophysiologie et imagerie des lésions d'ischémie-reperfusion myocardique, Caen F-14000, France; Department of Cardiology, CHU de Caen, Caen, F-14000, France.
  • Parienti JJ; Department of Biostatistics and Clinical Research, CHU de Caen, Caen, F-14000, France; Medical School, Université Caen Normandie, UNICAEN, CHU, Caen, EA2656 Groupe de Recherche sur l'Adaptation Microbienne (GRAM 2.0), Caen, F-14000, France.
  • Milliez P; Université Caen Normandie, Medical School, UNICAEN, CHU Caen, EA, 4650, Signalisation, électrophysiologie et imagerie des lésions d'ischémie-reperfusion myocardique, Caen F-14000, France; Department of Cardiology, CHU de Caen, Caen, F-14000, France.
Am Heart J ; 214: 88-96, 2019 08.
Article em En | MEDLINE | ID: mdl-31174055

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Fibrilação Atrial / Espironolactona / Ensaios Clínicos Controlados Aleatórios como Assunto / Ponte de Artéria Coronária / Antagonistas de Receptores de Mineralocorticoides Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Fibrilação Atrial / Espironolactona / Ensaios Clínicos Controlados Aleatórios como Assunto / Ponte de Artéria Coronária / Antagonistas de Receptores de Mineralocorticoides Idioma: En Ano de publicação: 2019 Tipo de documento: Article